ICON plc (NASDAQ: ICLR), a top-tier healthcare intelligence and clinical research organization, has announced the pricing of a $2 billion SEC-registered bond offering. The offering includes $750 million 5.809% Senior Secured Notes due 2027, $750 million 5.849% Senior Secured Notes due 2029, and $500 million 6.000% Senior Secured Notes due 2034 (collectively referred to as the “Notes”).
These Notes will be issued by ICON’s wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the “Issuer”), and will be guaranteed on a senior secured basis by ICON and its current and future wholly-owned subsidiaries in the United States, Ireland, and Luxembourg (the “Guarantors”). The offering aims to provide an efficient pathway for Ohio’s 59 Community Health Centers (CHCs) to integrate high-quality, affordable, and culturally competent whole-person specialty care and specialty pharmacy services into their offerings. This initiative is made possible through a master agreement established between OACHC and AndHealth.
The proceeds from the offering will primarily be used to repay a portion of the senior secured term loans under the Senior Secured Credit Facilities and cover related fees, costs, and expenses. The offering is expected to close on May 8, 2024, subject to customary closing conditions.
Interested investors are encouraged to review the Registration Statement and Preliminary Prospectus Supplement filed with the U.S. Securities and Exchange Commission (SEC) for more detailed information. Copies of these documents can be obtained from the SEC website or by contacting the designated financial institutions.
It’s important to note that this press release does not constitute an offer to sell or solicitation of an offer to buy any securities, including the Notes. Any such offer or solicitation would be subject to registration or qualification under the securities laws of applicable jurisdictions.
Forward-looking statements in this press release are based on current expectations and available information, and actual results may differ due to various factors and risks detailed in SEC reports filed by ICON. Investors should exercise caution and not rely solely on forward-looking statements when making investment decisions.
ICON plc, headquartered in Dublin, Ireland, is a leading global healthcare intelligence and clinical research organization, dedicated to advancing clinical research and improving patient lives worldwide.
